In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...